Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aom0304 in Symptomatic Hypertrophic Cardiomyopathy
NCT07675668Phase 2Not yet recruiting
- Sponsor
- Amckaus PTY LTD
- Start
- Oct 2026
- Primary completion
- Dec 2027
01
Overview
A Phase 2 trial of Aom-0304 in hypertrophic cardiomyopathy (HCM), sponsored by Amckaus PTY LTD. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
Aom-0304
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT07675668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07675668.